Crossmark

Patients’ and caregivers’ experiences of using continuous glucose monitoring to support diabetes self-management: qualitative study

Crossref DOI link: https://doi.org/10.1186/s12902-018-0239-1

Published Online: 2018-02-20

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lawton, J.

Blackburn, M.

Allen, J.

Campbell, F.

Elleri, D.

Leelarathna, L.

Rankin, D.

Tauschmann, M.

Thabit, H.

Hovorka, R.
Funding

Funding for this research was provided by:

JDRF
More Information

Article History

Received: 30 June 2017

Accepted: 8 February 2018

First Online: 20 February 2018

Ethics approval and consent to participate

: The study received approval from the independent Cambridge East Research Ethics Committee (REC ref. 15/EE/0324). Participants aged ≥16 years and parents or guardians of participants aged < 16 years signed informed consent; written assent was obtained from minors before study-related activities.

: Not applicable

: RH reports having received speaker honoraria from Eli Lilly, Novo Nordisk and Astra Zeneca, serving on advisory panel for Eli Lilly and Novo Nordisk, receiving license fees from BBraun and Medtronic; having served as a consultant to BBraun; patents and patent applications. MT reports having received speaker honoraria from Novo Nordisk and Medtronic. LL reports having received speaker honoraria from Medtronic, Animas, Sanofi and Novo Nordisk, serving on advisory panel for Animas, Medtronic and Novo Nordisk. JL, DR, MB, JMA, DE and HT have no conflicts of interest to disclose.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.